Two Sigma Investments, LP Ocuphire Pharma, Inc. Transaction History

Two Sigma Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$3.63 - $6.38 $69,282 - $121,768	19,086 New	19,086 $82,000
Q2 2022 Aug 15, 2022	SELL	$1.8 - $3.25 $93,060 - $168,025	-51,700 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.75 - $4.39 $187,550 - $299,398	-68,200 Reduced 56.88%	51,700 $168,000
Q4 2021 Feb 14, 2022	BUY	$3.4 - $5.19 $282,257 - $430,858	83,017 Added 225.08%	119,900 $447,000
Q3 2021 Nov 15, 2021	BUY	$3.84 - $5.38 $141,630 - $198,430	36,883 New	36,883 $190,000

2.58M

14.1K

800

Ticker OCUP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,579,800
Market Cap $20.2M
Description
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.